Ramos-Quiroga JA

Department of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Barcelona, Spain; Department of Mental Health, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute, Barcelona, Spain; Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain.

5 papers · ORCID

ArticleKetamine

Systematic review and meta-analysis of intranasal esketamine for treatment-resistant depression: Evidence from real-world studies.

de Oliveira Lapa C, Viola T, Delfino R +6

Europe PMC2026
ArticleKetamine

Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects.

Mora F, Ramos-Quiroga JA, Baca-García E +7

Europe PMC2025
ArticleKetamine

A Real-World Study on the Use, Effectiveness, and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression: INTEGRATE Study.

Molero P, Ibañez A, de Diego-Adeliño J +4

Europe PMC2025
ArticleKetamine

Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment.

Gutiérrez-Rojas L, Vendrell-Serres J, Ramos-Quiroga JA +10

Europe PMC2025
ArticleKetamine

Treating Treatment-resistant Depression with Esketamine Nasal Spray When All Therapeutic Options Have Been Exhausted: Clinical Experience from a Spanish Cohort of Expanded Use.

Vendrell-Serres J, Soto-Angona Ó, Rodríguez-Urrutia A +3

Europe PMC2024